Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Novo Nordisk A/S (NVO) had Operating Cash Flow per Share of $3.93 for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
$12.26B |
|
$4.03B |
|
$1.86B |
|
$10.40B |
|
$7.02B |
|
$5.24B |
|
$-172.91M |
|
$5.07B |
|
$5.07B |
|
$4.03B |
|
$4.03B |
|
$4.03B |
|
$4.03B |
|
$5.24B |
|
$5.97B |
|
4.45B |
|
4.46B |
|
$0.90 |
|
$0.90 |
|
| Balance Sheet Financials | |
$23.33B |
|
$23.56B |
|
$44.21B |
|
$67.54B |
|
$31.54B |
|
$13.00B |
|
$15.19B |
|
$46.73B |
|
$20.81B |
|
$4.70B |
|
$20.81B |
|
4.46B |
|
| Cash Flow Statement Financials | |
$17.54B |
|
$-18.69B |
|
$1.27B |
|
$2.09B |
|
$2.27B |
|
$183.13M |
|
$331.90M |
|
$-6.40B |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.74 |
|
-- |
|
-- |
|
0.38 |
|
0.72 |
|
84.81% |
|
42.77% |
|
42.77% |
|
-- |
|
41.36% |
|
32.84% |
|
$10.70B |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
0.31 |
|
0.97 |
|
93.04 |
|
19.35% |
|
85.72% |
|
5.96% |
|
11.91% |
|
$4.66 |
|
$2.40 |
|
|
Operating Cash Flow per Share |
$3.93 |